Recent Quotes
My Watchlist
Indicators
MJS Wisconsin Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

63.00 USD -0.01 (-0.02%)
Streaming Delayed Price Updated: 7:15 AM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Gilead to Present New Data at CROI 2021 Demonstrating the Company's Commitment to Addressing Urgent Global Health Needs
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV, hepatitis C virus (HCV), and COVID-19 research and development programs at the 28th... 
From Business Wire News Releases
NanoViricides Jumps On 'Strong Pan-Coronavirus Effectiveness' From 2 COVID-19 Candidates In Lab Studies
Shares of nano-cap biopharma NanoViricides, Inc. (NASDQ: NNVC) were trading solidly higher Tuesday following a positive data ... 
Tags Benzinga Movers NNVC
From Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ... 
Tags MRNA APHA Benzinga
From Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags FGEN AQST KNSA
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags XENE FGEN AQST
From Benzinga
Positive news on COVID vaccines weighs against concerns over new variants
The COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE has proved to be as effective in the real world as it was in clinical trials in the first major study of the two-dose... 
Tags PFE DJIA BNTX
From MarketWatch
3 Top-Rated Value Stocks to Buy in March
Growth stocks have delivered a stellar performance since the stock market retreat in mid-March. 
Tags Consumer Goods Market News Stocks / Equities
From Blogs - TalkMarkets
Is Galapagos Stock a Bad-News Buy Right Now?
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices. 
Tags GILD Market News GLPG
From Motley Fool
Noteworthy ETF Inflows: IBB, GILD, MRNA, ILMN
Symbols mentioned in this story: IBB, GILD, MRNA, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment
The following article is sponsored by Lantern Pharma. The information contained in this article in no way represents investment advice ... 
Tags General SGEN MRK
From Benzinga
Your 2 Best Profit Opportunities in 2021
Infinity Pharmaceuticals is my pick for Stock of the Year. And Shopify is my selection for Stock of the Decade. 
Tags RHHBY TRIL Market News
From Motley Fool
Big Tech is swallowing the rest of Silicon Valley
Silicon Valley's deepening descent into wealth inequality is particularly stark when comparing Big Tech with the San Francisco Bay Area's small businesses. 
Tags GILD GPRO AMZN
From MarketWatch
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ... 
Tags General INO Benzinga
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biotech stocks offer a textbook retracement pattern. The risk is low, and... 
Tags Trading Advice IBB Market News
From InvestorPlace
UN chief joins WHO in slamming rich countries for hogging COVID vaccines
The head of the United Nations has sharply criticized developed countries for hogging COVID-19 vaccines and called for a global effort to get all people in all countries vaccinated as soon as... 
Tags PFE MMM DJIA
From MarketWatch
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: 
From Business Wire News Releases
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
The biotech will get $345 million through an upfront payment and equity investment. 
Tags GILD ALNY VIR
From Motley Fool
Here's What Caused Royalty Pharma's Mixed Results in Q4
The company's royalties revenue soared, but its earnings sank. 
Tags MRK VRTX JNJ
From Motley Fool
Notable Tuesday Option Activity: GTHX, EXPI, GILD
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in G1 Therapeutics Inc (GTHX), where a total volume of 13,184 contracts has been... 
Tags Stocks
From Market News Video
Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new partnership with the Wake Forest University School of Divinity, one of the leading academic and faith-based institutions in the United States,... 
From Business Wire News Releases
These 3 Stocks Just Announced Dividend Increases That Boosted My Passive Income
Here are three stocks that are increasing dividends paid to their shareholders. 
Tags Stocks / Equities
From Blogs - TalkMarkets
10 Biggest Price Target Changes For Thursday
Morgan Stanley raised Simon Property Group Inc (NYSE: SPG) price target from $88 to $125. Simon Property shares rose 0.9% to $107.15 ... 
Tags Small Cap CERN LYFT
From Benzinga
Two-Third Patients Experienced No CRS/Neurologic Events Up To Three Days After Yescarta, New Data From LBCL Study Shows
Kite, aGilead Sciences Inccompany (NASDAQ:GILD), hasannounced new datafromthe ZUMA-1 Phase 1/2 ... 
Tags Benzinga Market News General
From Benzinga
4 Top COVID Stocks to Buy in February
Are you a high-risk stock picker or cautious investor? No matter your answer, there's a stock for you on this list. 
Tags REGN GILD LLY
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
A huge pivot could reopen doors to growth that seemed closed. 
Tags PFE Market News BNTX
From Motley Fool
Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma
Kite, a Gilead Company (Nasdaq: GILD), today announced findings from a new analysis of the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with relapsed or refractory large B-cell... 
From Business Wire News Releases
Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program
Despite solid signs of efficacy in mid-stage trials, the partners are shutting down all clinical trials with ziritaxestat. 
Tags GLPG Market News GILD
From Motley Fool
Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials
Galapagos NV(NASDAQ:GLPG) andGilead Sciences Inc(NASDAQ:GILD) havedecided to stopthe ... 
Tags FDA idiopathic pulmonary fibrosis GILD
From Benzinga
Notable ETF Outflow Detected - IBB, GILD, MRNA, ILMN
Symbols mentioned in this story: IBB, GILD, MRNA, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.